Vaping & Cancer Risk: New Research Links to Oral & Lung Disease

The decades-long lag between recognizing the harms of tobacco and definitively linking it to cancer is repeating itself with vaping. A comprehensive new review, published today, delivers the strongest evidence yet that nicotine-based vapes likely cause oral and lung cancers – a finding that shifts the conversation from vaping as a *potential* gateway to smoking, … Read more

Precision Oncology: New Advances & Future Potential

Beyond One-Size-Fits-All: How AI-Powered Precision Oncology is Rewriting the Future of Cancer Treatment Every two minutes, someone in the US dies from cancer. For decades, the standard approach – surgery, chemotherapy, and radiation – has been largely the same, often delivering a blunt force trauma to the body with varying degrees of success. But a … Read more

DNA Drug Targets Cancer: Precision & Programmability

The quest for cancer treatments that selectively destroy malignant cells while sparing healthy tissue has long been a central challenge in oncology. Now, a team at the University of Geneva (UNIGE) is offering a potentially revolutionary approach: “smart” drugs built from DNA that function like miniature computers, delivering potent payloads only when specific cancer markers … Read more

End-of-Life Care: “The Pitt” & Future Planning

Nearly 70% of Americans say they haven’t had conversations about their end-of-life wishes with their family, despite the fact that 82% believe it’s important to do so. This startling statistic underscores a widespread avoidance of a topic that will touch every single one of us. Now, a television drama, “The Pitt,” is unexpectedly thrusting these … Read more

Diabetes & Women’s Health: Care Gaps Identified in New Study

Diabetes & Beyond: Why Women’s Preventative Care is the Next Frontier in Personalized Medicine Nearly 1 in 5 women over 40 live with diabetes, yet a startling disparity exists in the preventative care they receive. A recent UCLA study, and supporting research, highlights that women with diabetes are significantly less likely to undergo crucial screenings … Read more

Pancreatic Cancer: How Metabolism Fuels Tumor Growth

Pancreatic cancer remains one of the most formidable challenges in oncology, largely due to its aggressive nature and late-stage diagnosis. A new study from the University of Michigan offers a critical shift in focus – moving *before* the tumor appears, targeting the very earliest stages of pancreatic cancer development. Researchers have pinpointed key metabolic changes … Read more

Stard7 & Gut Cancer: Unexpected Link & Development Role

Nearly 1.1 million people are diagnosed with colorectal cancer globally each year, and despite advancements in treatment, it remains a leading cause of cancer-related deaths. But what if a single protein, previously considered a supporting player, holds the key to unlocking more effective therapies? Emerging research suggests that Stard7, a steroidogenic acute regulatory protein, isn’t … Read more

Childhood Cancer in India: 10th Leading Cause of Death

The sobering reality is this: childhood cancer, a tragedy no family should face, is a growing global health crisis, particularly in the developing world. A new study published in The Lancet reveals cancer is now the 10th leading cause of death among children in India, and globally ranks as the eighth, surpassing diseases like measles, … Read more

HPV Throat Cancer: Blood Test for Personalized Treatment

Liquid Biopsies Poised to Revolutionize Throat Cancer Treatment – A New Era of Personalized Oncology Every year, approximately 22,000 individuals in the United States are diagnosed with oropharyngeal cancer – cancers of the back of the throat, including the base of the tongue and tonsils – linked to the human papillomavirus (HPV). For decades, treatment … Read more

Dual Drug & Immunotherapy Shrinks Tumors | Cancer News

A significant leap forward in cancer treatment has been demonstrated by researchers at Johns Hopkins University and the University of Maryland School of Pharmacy. Their development of novel drugs targeting hypoxia-inducible factors 1 and 2 (HIF-1/2) – often called “master regulators” of cancer – has shown the potential for complete tumor elimination in mice when … Read more